Clinical data | |
---|---|
Trade names | Vexol |
Other names | Trimexolone; Org 6216; 11β-Hydroxy-16α,17α,21-trimethylpregna-1,4-dien-3,20-dione |
AHFS/ Drugs.com | Monograph |
MedlinePlus | a606003 |
Routes of administration | Eye drops |
Drug class | Corticosteroid |
Pharmacokinetic data | |
Elimination half-life | estimated 1–2 hours |
Excretion | >80% faeces |
Identifiers | |
| |
Chemical and physical data | |
Formula | C24H34O3 |
Molar mass | 370.533 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Rimexolone, sold under the brand name Vexol, is a steroid medication used to treat inflammation of the eye. [1] This includes anterior uveitis and following surgery of the eye. [1] It is used as an eye drop. [1]
Common side effects include increased intraocular pressure, blurry vision, eye pain, redness, and a runny nose. [1] Other complications can include fungal infection of the cornea. [1]
Rimexolone was approved for medical use in the United States in 1994. [1] In the United States a 5 ml bottle costs about 100 USD as of 2021. [2] It is no longer available in the United Kingdom as of 2019. [3]
Clinical data | |
---|---|
Trade names | Vexol |
Other names | Trimexolone; Org 6216; 11β-Hydroxy-16α,17α,21-trimethylpregna-1,4-dien-3,20-dione |
AHFS/ Drugs.com | Monograph |
MedlinePlus | a606003 |
Routes of administration | Eye drops |
Drug class | Corticosteroid |
Pharmacokinetic data | |
Elimination half-life | estimated 1–2 hours |
Excretion | >80% faeces |
Identifiers | |
| |
Chemical and physical data | |
Formula | C24H34O3 |
Molar mass | 370.533 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Rimexolone, sold under the brand name Vexol, is a steroid medication used to treat inflammation of the eye. [1] This includes anterior uveitis and following surgery of the eye. [1] It is used as an eye drop. [1]
Common side effects include increased intraocular pressure, blurry vision, eye pain, redness, and a runny nose. [1] Other complications can include fungal infection of the cornea. [1]
Rimexolone was approved for medical use in the United States in 1994. [1] In the United States a 5 ml bottle costs about 100 USD as of 2021. [2] It is no longer available in the United Kingdom as of 2019. [3]